Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.14218/JCTH.2013.00018 http://scihub22266oqcxt.onion/10.14218/JCTH.2013.00018 C4521281!4521281!26355698     free     free     free       J+Clin+Transl+Hepatol 2013 ; 1 (2): 109-15 Nephropedia Template TP {{tp|p=26355698|t=2013. Update on Hepatitis C Virus and HIV Coinfection |pdf=|usr=}}{{26355698}} gab.com Text Update on Hepatitis C Virus and HIV Coinfection JO: J Clin Transl Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=26355698 #FOAvip Chronic hepatitis C virus (HCV) infection has historically been difficult to treat in the HIV-infected population, owing to generally poor responses to interferon-based therapies. The recent rapid development of directly acting antiviral agents (DAAs) against HCV has the potential to revolutionize treatment of this infection in the HIV population by improving tolerability and outcome, and, ultimately, reducing the significant burden of liver-related morbidity and mortality in this population. Clinical trials to address the safety and efficacy of novel DAAs in the HCV/HIV coinfected population are ongoing, and show much promise. The rapidity of current drug discovery in the field of HCV is both impressive and daunting for clinicians who will have to master these drugs. Going forward, the inclusion of individuals from this large and growing patient population in clinical trials will be of paramount importance. Twit Text FOAVip Update on Hepatitis C Virus and HIV Coinfection ????J Clin Transl Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=26355698 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26355698 #FOAvip English Wikipedia <ref>{{Cite pmid|26355698}}</ref> Update on Hepatitis C Virus and HIV Coinfection #MMPMID26355698 Gemtessa TA; Chirch LM J Clin Transl Hepatol 2013[Dec]; 1 (2): 109-15 PMID26355698show ga Chronic hepatitis C virus (HCV) infection has historically been difficult to treat in the HIV-infected population, owing to generally poor responses to interferon-based therapies. The recent rapid development of directly acting antiviral agents (DAAs) against HCV has the potential to revolutionize treatment of this infection in the HIV population by improving tolerability and outcome, and, ultimately, reducing the significant burden of liver-related morbidity and mortality in this population. Clinical trials to address the safety and efficacy of novel DAAs in the HCV/HIV coinfected population are ongoing, and show much promise. The rapidity of current drug discovery in the field of HCV is both impressive and daunting for clinicians who will have to master these drugs. Going forward, the inclusion of individuals from this large and growing patient population in clinical trials will be of paramount importance. äUpdate on Hepatitis C Virus and HIV Coinfection (epmc).pdf DeepDyve Pubget Overpricing